Conviction
$ Value
$4K
Shares
1,000
Price
$4
Filed
Jul 29
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ Cluster: 4 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Stauderman Kenneth A.
Title
Chief Scientific Officer
CIK
0001969388
Roles
Transaction Details
Transaction Date
2025-07-28
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
12,944
Footnotes
The sale of the common stock of CalciMedica, Inc. (the "Issuer") by the spouse of the reporting person reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person's spouse at a price of $1.85 per share on July 1, 2025. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $1,799.83, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
Filing Info
Stauderman Kenneth A.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-28 | CALC | ▲ | $4K ★ |
| 2025-07-25 | CALC | ▼ | $4K |
| 2025-07-01 | CALC | ▲ | $2K |
| 2025-06-24 | CALC | A | $0 |
| 2025-04-23 | CALC | A | $0 |
| 2025-04-05 | CALC | A | $0 |
Other Insiders at CALC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER
|
— | — | 2025-04-05 |
|
Roberts Eric W
CHIEF BUSINESS OFFICER
|
— | — | 2025-04-05 |
|
Bardin Stephen
Chief Financial Officer
|
— | — | 2025-04-05 |
|
Dunn Michael J.
President and COO
|
— | — | 2025-04-05 |
|
Hebbar Sudarshan
Chief Medical Officer
|
— | — | 2025-04-05 |
|
Stauderman Kenneth A.
Chief Scientific Officer
|
— | — | 2025-04-05 |